An innovative NIMH-funded trial shows that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders.
from NIMH News Feed https://ift.tt/3aw0tTD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment